Transcriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathy

A rapid and early diagnostic test to identify the encephalopathic babies at risk of adverse outcome may accelerate the development of neuroprotectants. We examined if a whole blood transcriptomic signature measured soon after birth, predicts adverse neurodevelopmental outcome eighteen months after n...

Descripción completa

Detalles Bibliográficos
Autores principales: Montaldo, Paolo, Cunnington, Aubrey, Oliveira, Vania, Swamy, Ravi, Bandya, Prathik, Pant, Stuti, Lally, Peter J., Ivain, Phoebe, Mendoza, Josephine, Atreja, Gaurav, Padmesh, Vadakepat, Baburaj, Mythili, Sebastian, Monica, Yasashwi, Indiramma, Kamalarathnam, Chinnathambi, Chandramohan, Rema, Mangalabharathi, Sundaram, Kumaraswami, Kumutha, Kumar, Shobha, Benakappa, Naveen, Manerkar, Swati, Mondhkar, Jayashree, Prakash, Vinayagam, Sajjid, Mohammed, Seeralar, Arasar, Jahan, Ismat, Moni, Sadeka Choudhury, Shahidullah, Mohammod, Sujatha, Radhika, Chandrasekaran, Manigandan, Ramji, Siddarth, Shankaran, Seetha, Kaforou, Myrsini, Herberg, Jethro, Thayyil, Sudhin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403382/
https://www.ncbi.nlm.nih.gov/pubmed/32753750
http://dx.doi.org/10.1038/s41598-020-70131-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403382/
https://www.ncbi.nlm.nih.gov/pubmed/32753750
http://dx.doi.org/10.1038/s41598-020-70131-w

Ejemplares similares